CRISPR PGD

Levrier guest post on CRISPR Consensus Meeting – “we all must get involved in this debate”

Guillaume-Levrier

By Guillaume Levrier Human germline editing has been done before. It will be done again in the future, as it is relatively easy to perform. No mechanism with the de facto ability to prevent it from being organized has yet been designed, let alone implemented. But the fact that germline editing has, can, and will …

Levrier guest post on CRISPR Consensus Meeting – “we all must get involved in this debate” Read More »

Countering that Pro-Heritable Human CRISPR WSJ Piece

human-embryo-modification

It’s germline, heritable human CRISPR time, right? Wrong. But the particularly enthusiastic supporters of heritable human CRISPR often cite hypothetical benefits in glowing terms, but either don’t mention risks or strongly downplay them. These fans also tend to leave alternative, proven and safe technologies such as preimplantation genetic diagnosis (PGD) out of the discussion or …

Countering that Pro-Heritable Human CRISPR WSJ Piece Read More »

Why Mitalipov’s ‘magic’ room for human embryo CRISPR may give us pause

Shoukhrat-Mitalipov

The debate over whether the main conclusions of the Nature paper on human embryo CRISPR led by Shoukhrat Mitalipov’s lab at Oregon Health Sciences University (OHSU) are correct remains unresolved. Note that Nature just added an editorial alert just above the references section to their paper: “Updated online 02 October 2017. Editorial Note: Readers are alerted that some …

Why Mitalipov’s ‘magic’ room for human embryo CRISPR may give us pause Read More »

Review of Mitalipov paper CRISPR’ing human embryos: transformative work on the edge

Human-embryo-CRISPR

In the same way perhaps that some excited relatives or parents-to-be both gush and worry about a baby before it is even born, our field has been transfixed for a week by the Mitalipov paper on CRISPR’ing human embryos even though the paper just now came out. Now that the paper is out, we can …

Review of Mitalipov paper CRISPR’ing human embryos: transformative work on the edge Read More »

The big blind spot on CRISPR for human embryo editing: PGD

blind-spot

There is a big old blind spot in the discussion over germline gene editing in humans: preimplantation genetic diagnosis (PGD). There’s been a lot of talk in 2015 about worries over how gene editing technology such as CRISPR might be used prematurely in the clinic in an unsafe or unethical manner in humans in the …

The big blind spot on CRISPR for human embryo editing: PGD Read More »